Literature DB >> 3582821

Changes in renal function in response to protein restricted diet in type 1 (insulin-dependent) diabetic patients.

M J Wiseman, E Bognetti, R Dodds, H Keen, G C Viberti.   

Abstract

Glomerular filtration rate, renal plasma flow and urinary albumin excretion rate were measured during insulin-induced euglycaemia in 12 male Type 1 (insulin-dependent) diabetic patients after a 3-week period of low protein diet (45 g/day) or a similar period on unchanged conventional diet (103 g/day). No changes in glycaemic control, indicated by home blood glucose profiles and serum fructosamine concentration, or in arterial pressure, were noted on either diet. On low protein diet, glomerular filtration rate was lower (p less than 0.001) in all patients, but there was no difference in renal plasma flow between low protein diet and normal protein diet; filtration fraction fell significantly on low protein diet (p less than 0.001). Fractional clearance of albumin was also lower (p less than 0.05) on low protein diet. This study suggests that reduction of dietary protein induces, independently of changes in plasma glucose and arterial pressure, modifications in glomerular filtration rate, filtration fraction and fractional clearance of albumin, which may be associated with a beneficial effect on the evolution of diabetic renal disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582821     DOI: 10.1007/bf00274220

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  30 in total

1.  The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics.

Authors:  H H Parving; I Noer; T Deckert; P E Evrin; S L Nielsen; J Lyngsoe; C E Mogensen; M Rorth; P A Svendsen; J Trap-Jensen; N A Lassen
Journal:  Diabetologia       Date:  1976-05       Impact factor: 10.122

2.  Errors in blood glucose determination.

Authors:  A de Pasqua; M B Mattock; R Phillips; H Keen
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

3.  Influence of protein intake on renal hemodynamics and plasma hormone concentrations in normal subjects.

Authors:  J Bergström; M Ahlberg; A Alvestrand
Journal:  Acta Med Scand       Date:  1985

4.  Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes.

Authors:  M J Wiseman; A J Saunders; H Keen; G Viberti
Journal:  N Engl J Med       Date:  1985-03-07       Impact factor: 91.245

Review 5.  The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.

Authors:  T H Hostetter; H G Rennke; B M Brenner
Journal:  Am J Med       Date:  1982-03       Impact factor: 4.965

6.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

Authors:  R Zatz; B R Dunn; T W Meyer; S Anderson; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

7.  Incipient nephropathy in type 1 (insulin-dependent) diabetes.

Authors:  E R Mathiesen; B Oxenbøll; K Johansen; P A Svendsen; T Deckert
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

8.  Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial.

Authors: 
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

9.  Adverse effect of proteins on remnant kidney: dissociation from that of other nutrients.

Authors:  D Laouari; C Kleinknecht; M C Gubler; M Broyer
Journal:  Kidney Int Suppl       Date:  1983-12       Impact factor: 10.545

10.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

View more
  8 in total

1.  Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.

Authors:  E Hommel; P Andersen; M A Gall; F Nielsen; B Jensen; P Rossing; J Dyerberg; H H Parving
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

2.  Early glomerular hyperfiltration and the development of late nephropathy in type 1 (insulin-dependent) diabetes mellitus.

Authors:  H H Lervang; S Jensen; J Brøchner-Mortensen; J Ditzel
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

3.  Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect.

Authors:  S Rudberg; A Aperia; U Freyschuss; B Persson
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

4.  Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.

Authors:  M Marre; G Chatellier; H Leblanc; T T Guyene; J Menard; P Passa
Journal:  BMJ       Date:  1988-10-29

5.  Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial.

Authors:  T Baba; S Murabayashi; K Takebe
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

6.  Reduction of protein intake decreases glomerular filtration rate in young type 1 (insulin-dependent) diabetic patients mainly in hyperfiltering patients.

Authors:  S Rudberg; G Dahlquist; A Aperia; B Persson
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

Review 7.  Protein restriction for diabetic renal disease.

Authors:  L Robertson; N Waugh; A Robertson
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 8.  Diabetic Kidney Disease Benefits from Intensive Low-Protein Diet: Updated Systematic Review and Meta-analysis.

Authors:  Qiuling Li; Feng Wen; Yanhui Wang; Sheng Li; Shaochun Lin; Chunfang Qi; Zujiao Chen; Xueqian Qiu; Yifan Zhang; Shaogui Zhang; Yiming Tao; Zhonglin Feng; Zhilian Li; Ruizhao Li; Zhiming Ye; Xinling Liang; Shuangxin Liu; Jianteng Xie; Wenjian Wang
Journal:  Diabetes Ther       Date:  2020-11-04       Impact factor: 2.945

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.